Anxiety management in Australian general practice: an analysis of encounters from 2006 - 2016.
Anxiety
General practice
Management
Primary care
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
04 08 2023
04 08 2023
Historique:
received:
02
09
2022
accepted:
19
07
2023
medline:
7
8
2023
pubmed:
5
8
2023
entrez:
4
8
2023
Statut:
epublish
Résumé
Anxiety disorders are highly prevalent mental health conditions managed predominantly by general practitioners (GPs). This study aimed to examine the management of anxiety by Australian GPs since the introduction of the Better Access to Psychiatrists, Psychologists and General Practitioners initiative in 2006. We conducted secondary analysis of Bettering the Evaluation and Care of Health data on GP encounters for anxiety from 2006 to 2016 (N = 28,784). We calculated point estimates and used multivariate logistic regression to explore the effect of GP and patient characteristics on rates and types of management. The management rate of anxiety increased from 2.3% of GP encounters in 2006 to 3.2% in 2016. Over the 10-year period, increases were seen in referrals to psychologists (AOR = 1.09, 95%CI = 1.07-1.11, p < .0001) and selective serotonin / serotonin-noradrenalin reuptake inhibitors (AOR = 1.05, 95%CI = 1.03-1.06, p < .0001), and benzodiazepines decreased (AOR = 0.94, 95%CI = 0.92-0.95, p < .0001). Systematic differences in management were found for patient and GP characteristics, including high rates of benzodiazepines in certain groups. Anxiety is accounting for more of the GP workload, year on year. GP management of anxiety has become more closely aligned with practice guidelines since 2006. However, high rates of benzodiazepine prescribing in certain groups remains a concern. Further research is needed into GP treatment decision making for anxiety.
Sections du résumé
BACKGROUND
Anxiety disorders are highly prevalent mental health conditions managed predominantly by general practitioners (GPs). This study aimed to examine the management of anxiety by Australian GPs since the introduction of the Better Access to Psychiatrists, Psychologists and General Practitioners initiative in 2006.
METHODS
We conducted secondary analysis of Bettering the Evaluation and Care of Health data on GP encounters for anxiety from 2006 to 2016 (N = 28,784). We calculated point estimates and used multivariate logistic regression to explore the effect of GP and patient characteristics on rates and types of management.
RESULTS
The management rate of anxiety increased from 2.3% of GP encounters in 2006 to 3.2% in 2016. Over the 10-year period, increases were seen in referrals to psychologists (AOR = 1.09, 95%CI = 1.07-1.11, p < .0001) and selective serotonin / serotonin-noradrenalin reuptake inhibitors (AOR = 1.05, 95%CI = 1.03-1.06, p < .0001), and benzodiazepines decreased (AOR = 0.94, 95%CI = 0.92-0.95, p < .0001). Systematic differences in management were found for patient and GP characteristics, including high rates of benzodiazepines in certain groups.
CONCLUSIONS
Anxiety is accounting for more of the GP workload, year on year. GP management of anxiety has become more closely aligned with practice guidelines since 2006. However, high rates of benzodiazepine prescribing in certain groups remains a concern. Further research is needed into GP treatment decision making for anxiety.
Identifiants
pubmed: 37542213
doi: 10.1186/s12875-023-02110-9
pii: 10.1186/s12875-023-02110-9
pmc: PMC10401842
doi:
Substances chimiques
Serotonin
333DO1RDJY
Benzodiazepines
12794-10-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
156Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Burgess PM, Pirkis JE, Slade TN, Johnston AK, Meadows GN, Gunn JM. Service use for mental health problems: findings from the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry. 2009;43(7):615–23.
doi: 10.1080/00048670902970858
Andrews G, Bell C, Boyce P, Gale C, Lampe L, Marwat O, Rapee R, Wilkins G. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Aust N Z J Psychiatry. 2018;52(12):1109–72.
doi: 10.1177/0004867418799453
National Institute for Health and Care Excellence. Anxiety disorders: quality standard. London: Author; 2014. https://www.nice.org.uk/guidance/qs53 .
Harris MG, Hobbs MJ, Burgess PM, Pirkis JE, Diminic S, Siskind DJ, Andrews G, Whiteford HA. Frequency and quality of mental health treatment for affective and anxiety disorders among Australian adults. Med J Aust. 2015;202(4):185–9.
doi: 10.5694/mja14.00297
Better Access to Psychiatrists, Psychologists and General Practitioners through the MBS (Better Access) initiative [ https://www.health.gov.au/internet/main/publishing.nsf/Content/mental-ba ].
Harrison C, Bayram C, Britt H. Suicide-related contacts–experience in general practice. Aust Fam Physician. 2013;42(9):605.
Harrison CM, Britt H, Harrison CM, Britt H. The rates and management of psychological problems in Australian general practice. Aust N Z J Psychiatry. 2004;38(10):781–8.
doi: 10.1080/j.1440-1614.2004.01462.x
Farrer LM, Walker J, Harrison C, Banfield M. Primary care access for mental illness in Australia: Patterns of access to general practice from 2006 to 2016. PLoS One. 2018;13(6):e0198400.
doi: 10.1371/journal.pone.0198400
Banfield M, Farrer LM, Harrison C. Management or missed opportunity? Mental health care planning in Australian general practice. Aust J Prim Health. 2019;25(4):332–8.
doi: 10.1071/PY18150
Harrison C, Britt H, Charles J. Better Outcomes or Better Access-which was better for mental health care? Med J Aust. 2012;197(3):170–2.
doi: 10.5694/mja12.10555
Britt H, Miller GC, Henderson J, Bayram C, Harrison C, Valenti L, Pan Y, Charles J, Pollack AJ, Wong C, et al. General practice activity in Australia 2015–16. In. Sydney: Sydney University Press; 2016.
Pirkis J, Currier D, Harris M, Mihalopoulos C. Evaluation of Better Access. Main Report. Parkville; 2022. https://www.health.gov.au/resources/publications/main-report-evaluation-of-the-better-access-initiative .
Baxter AJ, Vos T, Scott KM, Ferrari AJ. The global burden of anxiety disorders in 2010. Psychol Med. 2014;44(11):2363–74.
doi: 10.1017/S0033291713003243
Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327–35.
doi: 10.31887/DCNS.2015.17.3/bbandelow
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller H-J. Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012;16(2):77–84.
doi: 10.3109/13651501.2012.667114
Stephenson CP, Karanges E, McGregor IS. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry. 2013;47(1):74–87.
doi: 10.1177/0004867412466595
Australian Institute of Health and Welfare. Alcohol, tobacco & other drugs in Australia. Canberra: AIHW; 2021.
Australian Institute of Health and Welfare. Mental health services in Australia. Canberra: AIHW; 2021.
Britt H, Miller GC, Bayram C, Henderson J, Valenti L, Harrison C, Pan Y, Charles J, Pollack AJ, Chambers T, et al. A decade of Australian general practice activity 2006–07 to 2015–16. Sydney: Sydney University Press; 2016.
Family Medicine Research Centre. International Classification of Primary Care PLUS (ICPC-2 PLUS). Sydney: University of Sydney: FMRC; 1998.
Classification Committee of the World Organization of Family Doctors. ICPC-2: International Classification of Primary Care. 2nd ed. Oxford: Oxford University Press; 1998.
World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2016. Geneva: WHO; 2015.
Australian Bureau of Statistics. Socio-Economic Indexes for Areas 2011. 2013.
Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS): Volume 5 - Remoteness Structure. 2011.
SAS Institute Inc. SAS/ACCESS® 9.4 Interface to ADABAS: Reference. Cary: SAS Institute Inc.; 2013.
Austin PC, Hux JE. A brief note on overlapping confidence intervals. J Vasc Surg. 2002;36(1):194–5.
doi: 10.1067/mva.2002.125015
National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. London: Author; 2011. https://www.nice.org.uk/guidance/cg113 .
Dawel A, Shou Y, Smithson M, Cherbuin N, Banfield M, Calear AL, Farrer LM, Gray D, Gulliver A, Housen T et al. The effect of COVID-19 on mental health and wellbeing in a representative sample of Australian adults. Front Psychiatry. 2020;11(1026):579985.
Batterham PJ, Calear AL, McCallum SM, Morse AR, Banfield M, Farrer LM, Gulliver A, Cherbuin N, Rodney Harris RM, Shou Y, et al. Trajectories of depression and anxiety symptoms during the COVID-19 pandemic in a representative Australian adult cohort. Med J Aust. 2021;214(10):462–8.
doi: 10.5694/mja2.51043
The Royal Australian College of General Practitioners: Prescribing drugs of dependence in general practice, Part B - Benzodiazepines. Melbourne; 2015. https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/drugs-of-dependence/part-b .
Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013;43(5):897–910.
doi: 10.1017/S003329171200147X
Harris MG, Baxter AJ, Reavley N, Diminic S, Pirkis J, Whiteford HA. Gender-related patterns and determinants of recent help-seeking for past-year affective, anxiety and substance use disorders: findings from a national epidemiological survey. Epidemiol Psychiatr Sci. 2016;25(6):548–61.
doi: 10.1017/S2045796015000876
Delgado A, López-Fernández L-A. Luna JdD, Saletti-Cuesta L, Gil N, Jiménez M: The role of expectations in preferences of patients for a female or male general practitioner. Patient Educ Couns. 2011;82(1):49–57.
doi: 10.1016/j.pec.2010.02.028
Harrison CM, Britt HC, Charles J. Sex of the GP–20 years on. Med J Aust. 2011;195(4):192–6.
doi: 10.5694/j.1326-5377.2011.tb03278.x
Thompson A, Issakidis C, Hunt C. Delay to seek treatment for anxiety and mood disorders in an Australian clinical sample. Behav Chang. 2008;25(2):71–84.
doi: 10.1375/bech.25.2.71
Windle A, Elliot E, Duszynski K, Moore V. Benzodiazepine prescribing in elderly Australian general practice patients. Aust N Z J Public Health. 2007;31(4):379–81.
doi: 10.1111/j.1753-6405.2007.00091.x
Jorm AF, Grayson D, Creasey H, Waite L, Broe GA. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health. 2000;24(1):7–10.
doi: 10.1111/j.1467-842X.2000.tb00715.x
Sim MG, Khong E, Wain TD. The prescribing dilemma of benzodiazepines. Aust Fam Physician. 2007;36(11):923–6.
Cook JM, Marshall R, Masci C, Coyne JC. Physicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med. 2007;22(3):303–7.
doi: 10.1007/s11606-006-0021-3
National Institute for Health and Care Excellence. Social anxiety disorder: recognition, assessment and treatment. London: Author; 2013. https://www.nice.org.uk/guidance/cg159 .
Charles J, Valenti L, Britt H. GP visits by health care card holders A secondary analysis of data from Bettering the Evaluation and Care of Health (BEACH), a national study of general practice activity in Australia. Australian Fam Physician. 2003;32(1–2):85–8.
Bastos JL, Harnois CE, Paradies YC. Health care barriers, racism, and intersectionality in Australia. Soc Sci Med. 2018;199:209–18.
doi: 10.1016/j.socscimed.2017.05.010
Youssef J, Deane FP. Factors influencing mental-health help-seeking in Arabic-speaking communities in Sydney, Australia. Ment Health Relig Cult. 2006;9(1):43–66.
doi: 10.1080/13674670512331335686
Misev A, Phillips CB. Dangerous sadness: nervoza among first and second generation Macedonian immigrants to Australia. Ethn Health. 2019;24(3):301–11.
doi: 10.1080/13557858.2017.1332757
van Schaik DJF, Klijn AFJ, van Hout HPJ, van Marwijk HWJ, Beekman ATF, de Haan M, van Dyck R. Patients’ preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry. 2004;26(3):184–9.
doi: 10.1016/j.genhosppsych.2003.12.001
Mohlman J. A Community Based Survey of Older Adults’ Preferences for Treatment of Anxiety. Psychol Aging. 2012;27:1182–90.
doi: 10.1037/a0023126
Andrews G, Basu A, Cuijpers P, Craske MG, McEvoy P, English CL, Newby JM. Computer therapy for the anxiety and depression disorders is effective, acceptable and practical health care: an updated meta-analysis. J Anxiety Disord. 2018;55:70–8.
doi: 10.1016/j.janxdis.2018.01.001